Author:
Dixit Narendra M.,Layden-Almer Jennifer E.,Layden Thomas J.,Perelson Alan S.
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. World Health Organization, Hepatitis C—global prevalence (update). World Health Org. Weekly Epidemiol. Rec. 75, 18–19 (2000)
2. National Institutes of Health. Consensus Statement on Management of Hepatitis C. NIH Consens. State Sci. Statements 19, 1–46 (2002)
3. Manns, M. P. et al. Peginterferon α-2b plus ribavirin compared with interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 358, 958–965 (2001)
4. Fried, M. W. et al. Peginterferon α-2a plus ribavirin for chronic hepatitis C virus infection. N. Engl. J. Med. 347, 975–982 (2002)
5. Tan, S.-L., Pause, A., Shi, Y. & Sonenberg, N. Hepatitis C therapeutics: Current status and emerging strategies. Nature Rev. Drug Discov. 1, 867–881 (2002)
Cited by
313 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献